FDA Adverse Event Malfunction Summary report: N

ARCHITECT HAVAB IGM

MDR report key: 2142052 · Received June 28, 2011

Report

Report Number
3002809144-2011-00509
Event Type
Malfunction
Date Received
June 28, 2011
Date of Event
April 27, 2011
Report Date
June 3, 2011
Manufacturer
ABBOTT GERMANY
Product Code
LOL
PMA / PMN Number
K063329
Removal / Correction Number
2623532-1/4/10-001-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL DEVICE: ARCHITECT I1000SR ANALYZER, LIST # 1L86-01, SERIAL # (B)(4). RESULTS: CROSS CONTAMINATION WAS IDENTIFIED AS A POTENTIAL CAUSE. CONCLUSION: (B)(4). AN ADVERSE TREND IN US CUSTOMER COMPLAINTS FOR ARCHITECT HAVAB-IGM ASSAY (LIST NUMBER 6L21) REGARDING HIGHER THAN USUAL (B)(6) RESULTS RATE WAS DETECTED ON MARCH, 2009. THE INVESTIGATION REVEALED THE MOST PROBABLE CAUSE FOR THE INCREASE RATE OF (B)(6) RESULTS IS THE HAV ANTIGEN CODE 26286 WHICH HAS A REDUCED POTENCY THAT AFFECTS THE ARCHITECT HAVAB-IGM PERFORMANCE. (B)(4). AS A RESULT, THE SIGNAL TO NOISE RATIO IS SHIFTED SPECIALLY IN THE (B)(6) SAMPLES LEAVING THE ASSAY PRONE FOR FALSE (B)(6) RESULTS AND INCREASES ARCH HAVAB-IGM ASSAY SUSCEPTIBILITY TO REAGENT CROSS CONTAMINATION AND TEST SYSTEM VARIABILITY. AS A PREVENTIVE MEASURE TO PROTECT THE INTEGRITY OF TEST RESULTS, CUSTOMERS WERE INSTRUCTED BY A PRODUCT INFORMATION LETTER TO FOLLOW AN ALTERNATIVE PROCESSING METHOD BY SEGREGATING ALL HAVAB-IGM SAMPLES.

Additional Manufacturer Narrative · 1

UPON FURTHER REVIEW, THE CUSTOMER'S ISSUE IS NOT ASSOCIATED WITH REMEDIAL RECALL 2623532-1/4/10-001-C AND IS UNASSIGNED FROM THAT REMEDIAL ACTION.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED NINE OCCURRENCES OF ARCHITECT HAVAB-M (B)(6) RESULTS (NO DATA PROVIDED BY THE CUSTOMER) WHEN REAGENT LOT 95989HN00 WAS IN USE. THE HAVAB-M ASSAY CALIBRATION AND QUALITY CONTROLS WERE OK. THE CUSTOMER REPLACED THE REAGENT AND RE-RAN THE NINE (B)(6) SAMPLES AND OBTAINED (B)(6) RESULTS THAT WERE CONSISTENT WITH EXPECTATIONS. THERE WAS NO IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT HAVAB IGM LOL ABBOTT GERMANY 95989HN00

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT (B)(4) ANALYZER, LIST # (B)(4)| ARCHITECT (B)(4) ANALYZER, LIST # (B)(4)